These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 20670341
1. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis. Polak D, Wilensky A, Shapira L, Weiss EI, Houri-Haddad Y. J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341 [Abstract] [Full Text] [Related]
2. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. Polak D, Wilensky A, Shapira L, Halabi A, Goldstein D, Weiss EI, Houri-Haddad Y. J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440 [Abstract] [Full Text] [Related]
3. The role of coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection. Polak D, Shapira L, Weiss EI, Houri-Haddad Y. J Clin Periodontol; 2012 Jul; 39(7):617-25. PubMed ID: 22607053 [Abstract] [Full Text] [Related]
4. Strain-dependent activation of the mouse immune response is correlated with Porphyromonas gingivalis-induced experimental periodontitis. Wilensky A, Polak D, Awawdi S, Halabi A, Shapira L, Houri-Haddad Y. J Clin Periodontol; 2009 Nov; 36(11):915-21. PubMed ID: 19735468 [Abstract] [Full Text] [Related]
5. Protective potential of non-dialyzable material fraction of cranberry juice on the virulence of P. gingivalis and F. nucleatum mixed infection. Polak D, Naddaf R, Shapira L, Weiss EI, Houri-Haddad Y. J Periodontol; 2013 Jul; 84(7):1019-25. PubMed ID: 23030239 [Abstract] [Full Text] [Related]
6. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model. Gemmell E, Bird PS, Ford PJ, Ashman RB, Gosling P, Hu Y, Seymour GJ. Oral Microbiol Immunol; 2004 Aug; 19(4):247-51. PubMed ID: 15209995 [Abstract] [Full Text] [Related]
7. Porphyromonas gingivalis heat shock protein vaccine reduces the alveolar bone loss induced by multiple periodontopathogenic bacteria. Lee JY, Yi NN, Kim US, Choi JS, Kim SJ, Choi JI. J Periodontal Res; 2006 Feb; 41(1):10-4. PubMed ID: 16409250 [Abstract] [Full Text] [Related]
8. Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum. Onoue S, Imai T, Kumada H, Umemoto T, Kaca W, Isshiki Y, Kaneko A, Kawahara K. Microbiol Immunol; 2003 Feb; 47(1):51-5. PubMed ID: 12636253 [Abstract] [Full Text] [Related]
9. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model. Gemmell E, Bird PS, Carter CL, Drysdale KE, Seymour GJ. Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513 [Abstract] [Full Text] [Related]
10. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit. Takahashi Y, Kumada H, Hamada N, Haishima Y, Ozono S, Isaka M, Yasuda Y, Tochikubo K, Umemoto T. Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339 [Abstract] [Full Text] [Related]
11. The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model. Wilensky A, Polak D, Houri-Haddad Y, Shapira L. J Clin Periodontol; 2013 Oct; 40(10):924-32. PubMed ID: 23909600 [Abstract] [Full Text] [Related]
12. Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model. Gibson FC, Gonzalez DA, Wong J, Genco CA. Infect Immun; 2004 Apr; 72(4):2408-11. PubMed ID: 15039370 [Abstract] [Full Text] [Related]
13. Host modulation of tissue destruction caused by periodontopathogens: effects on a mixed microbial infection composed of Porphyromonas gingivalis and Fusobacterium nucleatum. Ebersole JL, Feuille F, Kesavalu L, Holt SC. Microb Pathog; 1997 Jul; 23(1):23-32. PubMed ID: 9250777 [Abstract] [Full Text] [Related]
14. Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss. Wilensky A, Potempa J, Houri-Haddad Y, Shapira L. J Periodontal Res; 2017 Apr; 52(2):285-291. PubMed ID: 27282938 [Abstract] [Full Text] [Related]
15. Subcutaneous vaccination with Porphyromonas gingivalis ameliorates periodontitis by modulating Th17/Treg imbalance in a murine model. Wang L, Guan N, Jin Y, Lin X, Gao H. Int Immunopharmacol; 2015 Mar; 25(1):65-73. PubMed ID: 25604387 [Abstract] [Full Text] [Related]
16. Synergistic pathogenicity of Porphyromonas gingivalis and Fusobacterium nucleatum in the mouse subcutaneous chamber model. Metzger Z, Lin YY, Dimeo F, Ambrose WW, Trope M, Arnold RR. J Endod; 2009 Jan; 35(1):86-94. PubMed ID: 19084132 [Abstract] [Full Text] [Related]
17. Virulence mechanism of bacteria in mixed infection: attenuation of cytokine levels and evasion of polymorphonuclear leukocyte phagocytosis. Polak D, Shapira L, Weiss EI, Houri-Haddad Y. J Periodontol; 2013 Oct; 84(10):1463-8. PubMed ID: 23259412 [Abstract] [Full Text] [Related]
19. The role of cytokines in a Porphyromonas gingivalis-induced murine abscess model. Alayan J, Gemmell E, Ford P, Hamlet S, Bird PS, Ivanovski S, Farah CS. Oral Microbiol Immunol; 2007 Oct; 22(5):304-12. PubMed ID: 17803627 [Abstract] [Full Text] [Related]
20. In vitro cytokine responses to periodontal pathogens: generalized aggressive periodontitis is associated with increased IL-6 response to Porphyromonas gingivalis. Borch TS, Holmstrup P, Bendtzen K, Nielsen CH. Scand J Immunol; 2010 Jun; 71(6):440-6. PubMed ID: 20500696 [Abstract] [Full Text] [Related] Page: [Next] [New Search]